Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 USD | -6.29% | -7.59% | -27.17% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.17% | 194M | |
-25.06% | 7.76B | |
+69.31% | 4.35B | |
+2.59% | 2.67B | |
-3.50% | 2.64B | |
-47.63% | 2.1B | |
-16.44% | 1.73B | |
-19.62% | 1.52B | |
+14.52% | 1.18B | |
-45.53% | 1.11B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcript : Biodesix, Inc., Q1 2022 Earnings Call, May 11, 2022